Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Revision of Prior Period, Accounting Standards Update, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Revision of Prior Period, Accounting Standards Update, Adjustment
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020     17,047,584      
Beginning balance at Dec. 31, 2020 $ 2,377 $ (3,107) $ 170 $ 121,729 $ (3,107) $ (119,522)
Issuances of common stock:            
Public offering of common stock (in shares)     2,127,660      
Public offering of common stock 46,785   $ 21 46,764    
Share-based compensation (in shares)     20,709      
Share-based compensation 320   $ 1 319    
Warrant and option exercises (cash and cashless) (in shares)     1,482,327      
Warrant and option exercises (cash and cashless) 145   $ 15 130    
Net loss for the period (2,538)         (2,538)
Ending balance (in shares) at Mar. 31, 2021     20,678,280      
Ending balance at Mar. 31, 2021 43,982   $ 207 165,835   (122,060)
Beginning balance (in shares) at Dec. 31, 2020     17,047,584      
Beginning balance at Dec. 31, 2020 2,377 $ (3,107) $ 170 121,729 $ (3,107) (119,522)
Issuances of common stock:            
Net loss for the period (10,261)          
Ending balance (in shares) at Sep. 30, 2021     22,855,187      
Ending balance at Sep. 30, 2021 44,120   $ 229 173,674   (129,783)
Beginning balance (in shares) at Mar. 31, 2021     20,678,280      
Beginning balance at Mar. 31, 2021 43,982   $ 207 165,835   (122,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of 2020 senior secured convertible note (in shares)     1,256,143      
Conversion of 2020 senior secured convertible note 7,131   $ 13 7,118    
Issuances of common stock:            
Share-based compensation (in shares)     26,435      
Share-based compensation 247     247    
Warrant and option exercises (cash and cashless) (in shares)     361,486      
Warrant and option exercises (cash and cashless) 349   $ 3 346    
Net loss for the period (3,743)         (3,743)
Ending balance (in shares) at Jun. 30, 2021     22,322,344      
Ending balance at Jun. 30, 2021 47,966   $ 223 173,546   (125,803)
Issuances of common stock:            
Share-based compensation (in shares)     126,805      
Share-based compensation 586   $ 1 585    
Warrant and option exercises (cash and cashless) (in shares)     435,802      
Warrant and option exercises (cash and cashless) 90   $ 5 85    
Payments for taxes related to net share settlement of equity awards (in shares)     (29,764)      
Payments for taxes related to net share settlement of equity awards (542)     (542)    
Net loss for the period (3,980)         (3,980)
Ending balance (in shares) at Sep. 30, 2021     22,855,187      
Ending balance at Sep. 30, 2021 $ 44,120   $ 229 173,674   (129,783)
Beginning balance (in shares) at Dec. 31, 2021 23,665,991   23,665,991      
Beginning balance at Dec. 31, 2021 $ 48,787   $ 237 182,482   (133,932)
Issuances of common stock:            
Share-based compensation (in shares)     29,916      
Share-based compensation 899     899    
Warrant and option exercises (cash and cashless) (in shares)     12,211      
Warrant and option exercises (cash and cashless) 3     3    
Net loss for the period (3,959)         (3,959)
Ending balance (in shares) at Mar. 31, 2022     23,708,118      
Ending balance at Mar. 31, 2022 $ 45,730   $ 237 183,384   (137,891)
Beginning balance (in shares) at Dec. 31, 2021 23,665,991   23,665,991      
Beginning balance at Dec. 31, 2021 $ 48,787   $ 237 182,482   (133,932)
Issuances of common stock:            
Option exercises (cash and cashless) (in shares) 29,000          
Net loss for the period $ (12,050)          
Ending balance (in shares) at Sep. 30, 2022 24,500,832   24,500,832      
Ending balance at Sep. 30, 2022 $ 39,878   $ 245 185,615   (145,982)
Beginning balance (in shares) at Mar. 31, 2022     23,708,118      
Beginning balance at Mar. 31, 2022 45,730   $ 237 183,384   (137,891)
Issuances of common stock:            
Share-based compensation (in shares)     379,122      
Share-based compensation 880   $ 4 876    
Warrant exercises (cash and cashless) (in shares)     367,006      
Warrant exercises (cash and cashless) 253   $ 4 249    
Issuance of common stock under employee stock purchase plan (in shares)     26,354      
Issuance of common stock under employee stock purchase plan 260     260    
Net loss for the period (4,303)         (4,303)
Ending balance (in shares) at Jun. 30, 2022     24,480,600      
Ending balance at Jun. 30, 2022 42,820   $ 245 184,769   (142,194)
Issuances of common stock:            
Share-based compensation (in shares)     20,738      
Share-based compensation 1,175     1,175    
Option exercises (cash and cashless) (in shares)     23,763      
Option exercises (cash and cashless) 7     7    
Payments for taxes related to net share settlement of equity awards (in shares)     (24,269)      
Payments for taxes related to net share settlement of equity awards (336)     (336)    
Net loss for the period $ (3,788)         (3,788)
Ending balance (in shares) at Sep. 30, 2022 24,500,832   24,500,832      
Ending balance at Sep. 30, 2022 $ 39,878   $ 245 $ 185,615   $ (145,982)